These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6860347)

  • 21. Systemic, bladder wall, and bladder tumor concentration of misonidazole following intravesical administration in the rat.
    Fathi MA; Fisher GJ; Pageau R; Tahan TW; Nigam VN; Brailovsky CA; Elhilali MM
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1397-400. PubMed ID: 6885552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
    Williams K; Begg E; Wade D; O'Shea K
    Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hepatic microsomal enzyme inducers on the metabolism of misonidazole in rats.
    Shoemaker D; Upton D; Strong J
    Cancer Treat Rep; 1980; 64(2-3):275-7. PubMed ID: 7407761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry of reduction of nitro heterocycles.
    Biaglow JE; Varnes ME; Roizen-Towle L; Clark EP; Epp ER; Astor MB; Hall EJ
    Biochem Pharmacol; 1986 Jan; 35(1):77-90. PubMed ID: 2934068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
    Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
    Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
    Workman P
    Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites.
    Shipley LA; Coleman MD; Brewer TG; Ashmore RW; Theoharides AD
    Xenobiotica; 1990 Jan; 20(1):31-44. PubMed ID: 2327106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor models.
    Mahy P; De Bast M; de Groot T; Cheguillaume A; Gillart J; Haustermans K; Labar D; Grégoire V
    Radiother Oncol; 2008 Dec; 89(3):353-60. PubMed ID: 18649964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular uptake of misonidazole and analogues with acidic or basic functions.
    Dennis MF; Stratford MR; Wardman P; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Jun; 47(6):629-43. PubMed ID: 3873433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and radiosensitization of 4,5-dimethylmisonidazole, a ring-substituted analog of misonidazole.
    Born JL; Smith BR; Harper N; Koch CJ
    Biochem Pharmacol; 1992 Mar; 43(6):1337-44. PubMed ID: 1562284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of misonidazole by rat liver microsomes and purified NADPH-cytochrome c reductase.
    McManus ME; Lang MA; Stuart K; Strong J
    Biochem Pharmacol; 1982 Feb; 31(4):547-52. PubMed ID: 6802140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of nitroheterocyclic compounds by mammalian tissues in vivo.
    Yeung TC; Sudlow G; Koch RL; Goldman P
    Biochem Pharmacol; 1983 Jul; 32(14):2249-53. PubMed ID: 6870947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of misonidazole enantiomers.
    Williams KM
    Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biliary and faecal excretion of misonidazole in man.
    Ash DV; Smith MR
    Br J Radiol; 1979 Oct; 52(622):846-8. PubMed ID: 509037
    [No Abstract]   [Full Text] [Related]  

  • 39. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro.
    Miller GG; Ngan-Lee J; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):741-4. PubMed ID: 7107408
    [No Abstract]   [Full Text] [Related]  

  • 40. Binding of nitroreduction products of misonidazole to nucleic acids and protein.
    Varghese AJ; Whitmore GF
    Cancer Clin Trials; 1980; 3(1):43-6. PubMed ID: 7389036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.